Cerebral metastasis from hepatoid adenocarcinoma of the stomach

Sheng Zhang1, Mi Wang, Yi-Hui Xue

  • 1Department of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian Province, China. zhgshg@126.com

Insights

This report details a rare case of gastric hepatoid adenocarcinoma (HAC) metastasizing to the brain. Accurate diagnosis using immunohistochemistry is crucial to differentiate from hepatocellular carcinoma (HCC) brain metastases.

Area of Science:

  • Gastroenterology and Oncology
  • Neuropathology
  • Medical Imaging

Background:

  • Gastric adenocarcinoma can rarely metastasize to the brain.
  • Hepatoid adenocarcinoma (HAC) is a rare subtype of gastric cancer with distinct histopathological features.
  • Accurate differentiation of brain metastases is critical for appropriate patient management.

Observation:

  • A 50-year-old patient presented with neurological symptoms including headache and visual disturbances.
  • MR imaging revealed a brain lesion consistent with a metastatic tumor.
  • The patient had a prior history of gastric adenocarcinoma treated with gastrectomy and subsequent liver metastasis management.

Findings:

  • Histopathological and immunohistochemical analysis confirmed the brain tumor was identical to the primary gastric tumor.
  • Tumor cells were positive for alpha-fetoprotein (AFP) and negative for Hep-Par-1, consistent with HAC.
  • The diagnosis was metastatic gastric hepatoid adenocarcinoma (HAC).

Implications:

  • This case highlights the importance of considering rare metastatic patterns of gastric cancer.
  • Immunohistochemistry, particularly using AFP and Hep-Par-1, is essential for differentiating gastric HAC brain metastases from hepatocellular carcinoma (HCC) metastases.
  • Early and accurate diagnosis can guide treatment strategies and improve patient outcomes.